Europe and Northern America vs Rwanda: Proportion of the target population who received a 3rd dose of
Europe and Northern America
83.0%
in 2024
Rwanda
98.0%
in 2024
Europe and Northern America rank
9th
Rwanda rank
7th
Proportion of the target population who received a 3rd dose of over time
- Europe and Northern America
- Rwanda
How they compare
Rwanda currently reports 98.0% against 83.0% in Europe and Northern America, a difference of 15.0%.
That makes Rwanda's figure about 1.2 times Europe and Northern America's.
Across all 15 years both countries report, Rwanda has been ahead every year.
Europe and Northern America ranks 9th and Rwanda ranks 7th of 37 groups.
Rwanda has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Europe and Northern America | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.4% | 97.7% | 31.3% | Rwanda |
| 2020s | 82.4% | 93.6% | 11.2% | Rwanda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Europe and Northern America or Rwanda?
- Rwanda, at 98.0% against 83.0% in Europe and Northern America as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Europe and Northern America and Rwanda?
- 15.0%, with Rwanda ahead.
- How many years of comparable data are there for Europe and Northern America and Rwanda?
- 15 years are reported by both, from 2010 to 2024.
- How do Europe and Northern America and Rwanda rank globally for proportion of the target population who received a 3rd dose of?
- Europe and Northern America ranks 9th and Rwanda ranks 7th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.